Filing Details
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedNASDAQ:EWTX
Edgewise Therapeutics, Inc. (EWTX) Reports Material Event to SEC
Filing Details Edgewise Therapeutics, Inc. (NASDAQ:EWTX) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market Context…
Market Context
Edgewise Therapeutics, Inc.'s stock currently trades at $41.27 with a market capitalization of $2.5B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Edgewise Therapeutics, Inc.'s stock.
All SEC filings for Edgewise Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View EWTX Stock Page
Frequently Asked Questions
Where can I read EWTX's SEC filings?
Browse all filings on our EWTX SEC filings page.
What types of SEC filings does Edgewise Therapeutics, Inc. file?
Public companies like Edgewise Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.